2019
DOI: 10.1038/s41431-019-0444-z
|View full text |Cite
|
Sign up to set email alerts
|

DEGS1 variant causes neurological disorder

Abstract: Sphingolipidoses are monogenic lipid storage diseases caused by variants in enzymes of lipid synthesis and metabolism. We describe an autosomal recessive complex neurological disorder affecting consanguineous kindred. All four affected individuals, born at term following normal pregnancies, had mild to severe intellectual disability, spastic quadriplegia, scoliosis and epilepsy in most, with no dysmorphic features. Brain MRI findings were suggestive of leukodystrophy, with abnormal hyperintense signal in the p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
27
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(29 citation statements)
references
References 19 publications
2
27
0
Order By: Relevance
“…In the brain, it is primarily expressed in the cerebellum, medulla, and hippocampus, with only small expression in the cortex and striatum. In humans, a homozygous missense mutation in DEGS1 was associated with a severe regressive neurological disease condition including intellectual disability, spastic paraplegia, and epilepsy 40 . Its specific function in the brain is currently unknown, but it may also be involved in the fine regulation of the balance between sphingolipids and dihydrosphingolipids 41 …”
Section: Discussionmentioning
confidence: 99%
“…In the brain, it is primarily expressed in the cerebellum, medulla, and hippocampus, with only small expression in the cortex and striatum. In humans, a homozygous missense mutation in DEGS1 was associated with a severe regressive neurological disease condition including intellectual disability, spastic paraplegia, and epilepsy 40 . Its specific function in the brain is currently unknown, but it may also be involved in the fine regulation of the balance between sphingolipids and dihydrosphingolipids 41 …”
Section: Discussionmentioning
confidence: 99%
“…Jung et al (2017) show that eye-specific ifc-KO results in activity-dependent neurodegeneration and demonstrated that ifc can function cell non-autonomously. Inherited DEGS1 deficiencies lead to hypomyelination in the central and peripheral nervous systems (Dolgin et al, 2019, Karsai et al, 2019, Pant et al, 2019). Since exosomes are important for myelination and demyelination, whether altered exosome production is the underlying cause of defects seen in patients with inherited DEGS1 deficiencies warrants further investigation.…”
Section: Discussionmentioning
confidence: 99%
“…Three recent reports linked variants of the human dhCer desaturase gene, DEGS1 , to leukodystrophy and systemic neuropathy (Dolgin et al, 2019, Karsai et al, 2019, Pant et al, 2019). These reports not only confirm an essential role for DEGS1 in the human nervous system, but they also showed that loss-of-function mutations of DEGS1 cause significant accumulation of dhCer and a shift of cellular sphingolipid pool towards the dihydro forms.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Notably, the defects of ifc-KO flies were rescued by overexpression of a human homolog, DEGS1, suggesting functional conservation between fly and human. In 2019, three independent investigations described the association of DEGS1 loss-of-function variants with leukodystrophy and systemic neuropathy (Dolgin et al, 2019;Karsai et al, 2019;Pant et al, 2019). Despite the clinical descriptions in patients and phenotypic characterization of the fly model, the pathophysiological role of ifc/DEGS1 and dihydroceramide in the nervous system remains poorly understood.…”
Section: Introductionmentioning
confidence: 99%